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Abstract
The issue addressed in the paper published by the Italian National Bioethics Committee 
(NBC) entitled “Clinical ethics committees”, is highly significant for many reasons. One 
of these is the fact that the ethics committees charged with assessing clinical trials have 
so much responsibility and such a heavy work-load that they have little time available for 
other tasks such as engaging directly with patients “at the bedside”, as a result of which 
the role of committees responsible for assessing clinical cases is especially important. 
According to the NBC, the opinions of clinical ethics committees should be formulated 
jointly and are non-binding. The NBC offers practical proposals not only for the Italian 
context. While the Italian National Institute of Health (Istituto Superiore di Sanità – 
ISS) is not involved directly in treating patients, its role in providing guidance is crucial 
to the national health service and it has always paid special attention to these issues.
On 31st March 2017 the Italian National Bioethics 
Committee (NBC) unanimously approved a docu-
ment entitled “Clinical ethics committees” [1]1. The 
issues related to such committees are of some impor-
tance on the Italian bio-political scene, as the ques-
tion of how to provide guidance on clinical ethics “at 
the bedside” is still unresolved. This is due in partic-
ular to developments in legislation governing ethics 
committees in much of the European Union. In Italy, 
as in many other European nations, current legisla-
tion [2] governing the establishment, organisation 
and functioning of ethics committees assigns to these 
bodies a crucial role in the assessment and authorisa-
tion of trials of drugs and medical devices, a role that 
is further emphasised in Regulation 536/2014 of the 
European Parliament and the Council of Europe [3], 
which lays down precise and binding rules for the as-
sessment and authorisation of clinical trials. The time 
devoted by these committees to assessing trials leaves 
them little time for other issues such as clinical ethics, 
in particular.
For this reason the document approved by the NBC 
focuses on committees dedicated specifically to issues 
of clinical ethics. It proposes minimum requisites con-
1 The NBC Working Group that drew up the document was coordi-
nated by Carlo Petrini, co-author of the present paper, and by Salvatore 
Amato and Cinzia Caporale.
cerning their independence, the procedures for consul-
tation, their structure, composition, tasks, location, co-
ordination, responsibilities and regulation. The NBC 
argues that clinical ethics opinions should not relieve 
physicians of their responsibility and should be formed 
jointly, in other words not by an individual expert. This 
is not intended in any way to belittle the valuable role 
in bioethics of experts or of the ethical guidance servic-
es provided in some healthcare facilities. The decision 
to dedicate the document exclusively to clinical ethics 
committees does not imply a failure by the NBC to 
recognise the importance of such experts and guidance 
services in a healthcare setting [4]: in fact, the docu-
ment cites examples from other countries, where such 
centres are known by varying names, including the par-
ticularly evocative term “clinical space” used in France. 
The NBC document does not devote too much space 
specifically to experts in bioethics or to clinical ethics 
centres solely because to do so would call for a sepa-
rate document, which the Committee hopes to be able 
to produce in the future.
In reiterating the need for ethics opinions to be 
formed jointly, the NBC is adhering strictly, at a time of 
extremely delicate ethical decisions, to three basic prin-
ciples of clinical bioethics: interdisciplinarity, pluralism 
and the physician/patient or healthcare team/patient re-
lationship. The need to safeguard the physician/patient 
relationship is also one of the reasons why the NBC 
deems it essential that the opinions of clinical ethics 
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committees should be considered as a guide and are not 
binding. Another requisite considered indispensable by 
the NBC is the independence of clinical ethics commit-
tees from the structures that establish them and from 
the institutions in which they operate.
The practical suggestions proposed by the NBC for 
the establishment and functioning of clinical ethics 
committees are particularly helpful. It is specifically 
recommended that the committees should include at 
least one of each of the following professional experts: 
clinical physician, bioethicist, nurse, jurist, health risk 
expert, patient representative, epidemiologist. The spe-
cialist areas that the NBC considers should be repre-
sented include, in particular: the foundations of ethics 
and moral theories; clinical medicine, with a special fo-
cus on the diseases treated in the specific facility; the 
socio-cultural background of patients, with the provi-
sion of specific forms of cultural mediation; ethical 
codes and documents relating to healthcare providers; 
elements of bio-law and healthcare regulations; national 
and international guidelines on issues of medical ethics; 
the organisation of health services. Members of these 
committees should not only have the appropriate train-
ing and experience, but should also have constantly at-
tended refresher seminars.
Clinical ethics committees can provide a valuable 
contribution to the strengthening and improvement of 
relations between physicians and patients: the opinions 
and guidance they offer can help to formulate helpful 
suggestions for solutions to the most challenging situ-
ations.
Although the Italian National Institute of Health (Is-
tituto Superiore di Sanità – ISS) is not a treatment facil-
ity directly involved in the care of patients, its respon-
sibilities include both clinical trials and clinical practice 
[5], so that the issue of clinical ethics committees is of 
considerable importance. Another reason these com-
mittees are accorded particular attention concerns their 
potential role in the interpretation and application of 
guidelines. The recent Italian legislation on the safety 
of treatment and the professional liability of healthcare 
providers [6] assigns both a key role in clinical practice 
to guidelines, and crucial responsibility for guidelines 
to the ISS. The latter publishes guidelines “after check-
ing that the approved procedures meet the standards 
defined and made publicly available by the ISS and that 
the scientific proof offered in support of the recommen-
dations is relevant”.
While the primary focus of the NBC document is on 
Italy, it also offers a broad overview of clinical ethics 
committees and refers to the experience of other na-
tions. It is thus useful as a reference document beyond 
Italy for patients, physicians, healthcare professionals 
and facilities, patient associations, national and region-
al health safety bodies, community groups operating in 
the biomedical field, and legislators.
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